Navigation Links
Study Links Blood Type and Pancreatic Cancer
Date:3/10/2009

Findings shed light on gene serving as marker for others involved in tumor development

TUESDAY, March 10 (HealthDay News) --- People with type O blood have a much lower risk of developing pancreatic cancer, a finding that might help explain the origins of the often fatal disease.

The study, by researchers at the Dana-Farber Cancer Institute in Boston, confirms a previously suggested tie between blood type and the disease, which is diagnosed in about 40,000 people each year in the United States.

The study found that the chances of developing pancreatic cancer were greater for people with a blood type other than O: 32 percent higher for those with type A blood, 51 percent greater for type AB and 72 percent higher for type B .

However, because only a little more than 1 percent of the general population is at risk for the disease, the researchers said that blood type would not serve as a helpful screening method in the future.

"Except for several rare familial syndromes, the genetic factors that raise or lower an individual's risk for pancreatic cancer are largely unknown," the study's lead author, Dr. Brian Wolpin, said in a news release from the cancer institute.

"The association between blood type and pancreatic cancer risk provides a new avenue for getting at the biological mechanisms that underlie the disease," he said. "Understanding the biology will put us in a better position to intervene so the cancer doesn't develop or progress."

Glycoproteins, compounds of sugar and protein found on the surface of red blood cells and other cells, including those in the pancreas, help define the four major blood types. A gene called ABO helps put these glycoproteins together by arranging sugar molecules on a protein "backbone" called the H antigen. In people with type O blood, the antigen has no sugars attached to it.

Previous studies have found that normal pancreas cells have blood-type antigen patterns that differ from those in pancreatic tumor cells, leading to speculation that the ABO gene might have a role in determining whether cells become cancerous.

The authors, whose study was published online in the Journal of the National Cancer Institute, wrote that their findings do not necessarily prove a direct link between blood-type antigens and pancreatic cancer development, but they may show that the ABO gene serves as a marker for other genes more directly involved in cancer development.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: Dana-Farber Cancer Institute, news release, March 10, 2009



-- Kevin McKeever



SOURCE: Dana-Farber Cancer Institute, news release, March 10, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study identifies risk factors in severity of flat head syndrome in babies
2. New Study Shows That One-Third of Shelter Youth Have Been Institutionalized; Almost One-Half Suffered Violence in the Home
3. Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence
4. Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows
5. Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse
6. Study Shows 80% of Adults with Peripheral Arterial Disease Go Undiagnosed
7. Study finds pay for performance stimulates changes in medical practice
8. Study: Doctor-patient conversations at end of life associated with lower medical expenses
9. Study tests reliability of more accurate measure of patient pain
10. New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients
11. Study prompts new mandate for N.C. high schools
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Links Blood Type and Pancreatic Cancer
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: